2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing
Journal Articles
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
status
publication date
published in
Research
keywords
-
AF, atrial fibrillation
-
ATP, antitachycardia pacing
-
Bradycardia mode and rate
-
CI, confidence interval
-
CL, cycle length
-
CRT, cardiac resynchronization therapy
-
CRT-D, cardiac resynchronization therapy–defibrillator
-
DT, defibrillation testing
-
Defibrillation testing
-
EEG, electroencephalography
-
EGM, electrogram
-
HF, heart failure
-
HR, hazard ratio
-
ICD, implantable cardioverter-defibrillator
-
Implantable cardioverter-defibrillator
-
LV, left ventricle
-
LVEF, left ventricular ejection fraction
-
MI, myocardial infarction
-
MVP, managed ventricular pacing
-
NCDR, National Cardiovascular Data Registry
-
NYHA, New York Heart Association
-
OR, odds ratio
-
PEA, peak endocardial acceleration
-
PVC, premature ventricular contraction
-
Programming
-
RCT, randomized clinical trial
-
RV, right ventricle
-
S-ICD, subcutaneous implantable cardioverter-defibrillator
-
SCD, sudden cardiac death
-
SVT, supraventricular tachycardia
-
TIA, transient ischemic attack
-
Tachycardia detection
-
Tachycardia therapy
-
VF, ventricular fibrillation
-
VT, ventricular tachycardia (Heart Rhythm 2015;0:1–37)
-
aCRT, adaptive cardiac resynchronization therapy
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue